Laboratory Confirmation and Diagnostic Workup for Iron Deficiency Anemia in Adolescent with Heavy Menstrual Bleeding
A serum ferritin ≤15 μg/L confirms iron deficiency anemia in this 15-year-old, and according to CDC/AAP guidance, she requires screening for an underlying bleeding disorder given her heavy menstrual bleeding presentation 1.
Laboratory Findings That Confirm Iron Deficiency Anemia
The pending ferritin result is the critical confirmatory test. Based on current guidelines:
- Serum ferritin ≤15 μg/L definitively confirms iron deficiency 1
- Ferritin >15 μg/L but <30 μg/L still indicates depleted iron stores 2
- The combination of low hemoglobin (10.2 g/dL, below the 12.0 g/dL threshold for adolescent females), low MCV (74 fL indicating microcytosis), and low ferritin establishes the diagnosis 1
Additional confirmatory laboratory tests if ferritin is equivocal or elevated due to inflammation:
- Transferrin saturation <30% supports iron deficiency 3
- Red cell distribution width (RDW) - typically elevated in iron deficiency 1
- Reticulocyte count - should be low or inappropriately normal for the degree of anemia 4
- Percentage of hypochromic red cells or reticulocyte hemoglobin if available 4, 2
Required Additional Diagnostic Workup
1. Bleeding Disorder Evaluation (Critical Priority)
ACOG explicitly recommends screening for bleeding disorders in adolescents with heavy menstrual bleeding 5. This patient's presentation—7-8 day duration, fatigue, orthostatic dizziness, and anemia—strongly suggests a bleeding disorder.
Required hematology workup includes:
- Von Willebrand disease screening (most common inherited bleeding disorder in adolescents with HMB) 6, 7, 8
- Platelet count and function studies
- Coagulation studies (PT/PTT)
- Factor VIII and von Willebrand factor antigen and activity 6, 7
Coordinate with hematology for comprehensive bleeding disorder evaluation 5, 6. The prevalence of bleeding disorders is significantly elevated in adolescents presenting with HMB compared to the general population 6, 8.
2. Repeat Hemoglobin/Hematocrit
CDC guidelines recommend confirming the initial anemia screening with a repeat test 1. If results agree, proceed with presumptive diagnosis and treatment.
3. Assessment of Hemodynamic Stability
Measure orthostatic blood pressure and pulse given her reported orthostatic dizziness 5. This determines whether she requires acute intervention versus outpatient management.
4. Endocrine Evaluation for Anovulation
Screen for thyroid dysfunction and other endocrine disorders that cause anovulatory bleeding 5. While anovulation is the most common cause of HMB in adolescents, the severity of her anemia and symptoms warrant bleeding disorder evaluation regardless 6.
Treatment Initiation
Start iron supplementation immediately while awaiting complete workup:
- Oral iron: 60-120 mg elemental iron daily for adolescent females 1
- Administer between meals for optimal absorption 1
- Recheck hemoglobin in 4 weeks: An increase ≥1 g/dL confirms iron deficiency anemia diagnosis 1
Iron deficiency is extremely common but under-recognized and under-treated in adolescents with HMB 9, 10. Studies show that only 8.9% of adolescents presenting to emergency departments with HMB had ferritin checked, and 78.3% of those tested had iron deficiency 9. Furthermore, screening with hemoglobin alone misses over half of iron deficiency cases in this population 10.
Critical Pitfalls to Avoid
- Do not assume dietary insufficiency alone—heavy menstrual bleeding with this degree of anemia mandates bleeding disorder evaluation 5, 6, 8
- Do not rely on hemoglobin or MCV alone to exclude iron deficiency—ferritin is essential 10
- Do not delay hematology referral—diagnostic delays in identifying bleeding disorders result in significant morbidity and missed opportunities for family screening 8
- Do not overlook iron deficiency even if ferritin is "normal" in the 15-30 μg/L range—this still indicates depleted stores 2
Follow-Up Protocol
After confirming iron deficiency and initiating treatment:
- Recheck hemoglobin at 4 weeks (should increase ≥1 g/dL) 1
- Continue iron for 2 additional months after hemoglobin normalizes 1
- Recheck hemoglobin/ferritin 6 months after completing treatment 1
- If no response to iron after 4 weeks despite compliance, further evaluate with additional tests and consider alternative diagnoses 1
The combination of severe anemia, prolonged heavy menstrual bleeding, and symptomatic presentation (fatigue, orthostatic dizziness) in an adolescent mandates both iron repletion and comprehensive bleeding disorder evaluation 5, 6, 8.